100
Participants
Start Date
September 30, 2025
Primary Completion Date
March 31, 2026
Study Completion Date
June 30, 2026
Intravenous caffeine
"Group assigned to receive caffeine will receive intravenous(IV) caffeine and sodium benzoate infusion starting at 250-500 mg.~This method will use an automated algorithm that adjusts the flow of the infusion depending on the individual's sex and weight and then in a serial fashion in response to blood caffeine measurements. Serial blood caffeine measurements at pre-determined intervals according to the algorithm will be until a steady state is obtained."
Masked Placebo
"The patients assigned to the masked placebo will receive 5% dextrose in 0.45% saline using the same infusion protocol for a random length of time that was within 1 standard deviation(SD) of the mean time to achieve a steady state using the caffeine protocol (17+4 min).~To maintain blinding, caffeine blood concentration measurements that will be randomly generated within 2 SDs of the predicted values calculated by the algorithm will be used and verbally communicated for placebo infusions."
Research Medical Center Clinic, Kansas City
Research Medical Center, Kansas City
Centerpoint Medical Center Clinic, Independence
Centerpoint Medical Center, Independence
Menorah Medical Center, Overland Park
Kansas City Heart Rhythm Institute, Overland Park
Overland Park Regional Medical Center, Overland Park
Texas Cardiac Arrythmia Institute, Austin
Loma Linda University, Loma Linda
Kansas City Heart Rhythm Institute, Overland Park, KS
UNKNOWN
Texas Cardiac Arrhythmia Institute, Austin, TX, USA
UNKNOWN
Loma Linda University, Loma Linda, California, USA
UNKNOWN
Kansas City Heart Rhythm Research Foundation
OTHER